Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.

about

Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.

Item

http://www.wikidata.org/entity/Q46623831

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Daily inhibition of postprandi ...... y streptozotocin-treated rats.

@en

Daily inhibition of postprandi ...... y streptozotocin-treated rats.

@nl

type

Item

label

Daily inhibition of postprandi ...... y streptozotocin-treated rats.

@en

Daily inhibition of postprandi ...... y streptozotocin-treated rats.

@nl

prefLabel

Daily inhibition of postprandi ...... y streptozotocin-treated rats.

@en

Daily inhibition of postprandi ...... y streptozotocin-treated rats.

@nl

P1476

Daily inhibition of postprandi ...... ly streptozotocin-treated rats

@en

P2093

Furukawa N

http://www.w3.org/2001/XMLSchema#string

Matsui K

http://www.w3.org/2001/XMLSchema#string

Matsushita M

http://www.w3.org/2001/XMLSchema#string

Miyajima K

http://www.w3.org/2001/XMLSchema#string

Sasase T

http://www.w3.org/2001/XMLSchema#string

Yonemori F

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound.

Sulfonylureas.

JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.

The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.

Renal function in the noninsulin-dependent diabetic rat: effects of unilateral nephrectomy.

JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats.

The U.K. Prospective Diabetes Study. A review.

Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.

P304

517-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1463-1326.2004.00419.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takeshi Ohta

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16050944

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia